- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06820814
The Association Between Physical Symptoms and Depression Among Medical Students in Egypt
Study Overview
Status
Conditions
Detailed Description
The Google Form will be open for one week from the start of the academic term. It is divided into three parts:
Demographic Data - which includes age, academic level, relationship status, and whether the student intends to work while studying.
Patient Health Questionnaire PHQ-9: Assesses symptoms of poor mental health in the two weeks prior to the start of term.
Patient Health Questionnaire PHQ-15: This is a measure of physical symptoms felt in the week prior to the commencement of the academic term.
The questionnaire will be distributed among different medical faculties in Egypt and all students will be required to fill it out. Data analysis will be done through SPSS to explore the relationship between psychological and physical symptoms.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Giza
-
Cairo, Giza, Egypt
- Cairo university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Medical students enrolled in any medical program in Egypt.
- Age range: Typically 19 to 30 years (or based on your study's demographic focus).
- Willingness to participate and provide informed consent.
- Self-reported symptoms of depression: Those who indicate moderate to severe symptoms on screening tools (e.g., PHQ-9).
- Physical symptoms: Those who report experiencing physical symptoms (e.g., headaches, fatigue, gastrointestinal discomfort, etc.) on a checklist.
Exclusion Criteria:
- Non-medical students (students outside of the medical program).
- Students with a history of major medical conditions that may confound the physical symptoms (e.g., chronic diseases like diabetes, hypertension, or neurological disorders).
- Students with a diagnosed psychiatric disorder (e.g., bipolar disorder, schizophrenia, etc.) or those already undergoing psychiatric treatment.
- Non-consenting individuals: Students who decline to participate in the study or do not provide informed consent.
- Incomplete responses: Students who fail to provide adequate or valid responses in the questionnaires.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PATIENT HEALTH QUESTIONNAIRE (PHQ-9)
Time Frame: 1 week
|
The Patient Health Questionnaire-9 (PHQ-9) used for screening, diagnosing, monitoring, and measuring the severity of depression. It consists of nine questions; Each item is scored from 0 (Not at all) to 3 (Nearly every day), leading to a total score ranging from 0 to 27. Scores can be categorized as follows: 1-4: Minimal or no depression 5-9: Mild depression 10-14: Moderate depression 15-19: Moderately severe depression 20-27: Severe depression |
1 week
|
|
PATIENT HEALTH QUESTIONNAIRE PHYSICAL SYMPTOMS (PHQ-15)
Time Frame: 1 week
|
PATIENT HEALTH QUESTIONNAIRE PHYSICAL SYMPTOMS (PHQ-15) used to assess the severity of somatic (physical) symptoms. Consists of 15 common physical symptoms (e.g., stomach pain, dizziness, fatigue). Each symptom is rated based on how much it has bothered the individual in the past 7 days. Scoring system: 0 = Not bothered at all
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOT YET (Other Grant/Funding Number: Canakkale Onsekiz Mart University)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression Anxiety Disorder
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
University College, LondonEnrolling by invitationDepression Anxiety Disorder | Depression - Major Depressive DisorderUnited Kingdom
-
University Hospital, Strasbourg, FranceRecruitingDepression Anxiety DisorderFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
University of California, IrvineActive, not recruiting
-
Universitat Jaume IHospital Universitari Mutua TerrassaNot yet recruitingAnxiety Disorders | Depression Anxiety Disorder | Emotional Disorders | Depression DisordersSpain
-
Mazra Mental Health CenterThe Academic College of Tel-Aviv YaffoUnknown
-
Region StockholmKarolinska InstitutetEnrolling by invitationGeneralized Anxiety Disorder | Depression NOSSweden
-
Beykoz UniversityUskudar University; Istanbul Nisantasi UniversityRecruitingAnxiety | Depression Anxiety DisorderTurkey